This interview is a continuation of a throwback mini-series that I’ve been releasing over the past few weeks with some of my favorite Medsider guests of all time.

One of which is Lisa Suennen, who was then a Managing Member of Psilos Group, a healthcare-focused venture capital firm with approximately $600 million under management. Although this discussion is several years old and the audio quality isn’t the best, the insights Lisa provides are timeless. Here are some of the things we covered:

• What does Lisa think when the goal of physicians is to “dagger historical price lists."
• Why Lisa and her partners at the Psilos Group favor late-stage deals.
• Corporate venture capital arms: friend or foe? 
• And if you’re an early-stage medical device company, what is the best way to get the attention of Lisa Suennen and her peers in the VC world?

See more...